Fundamental Data for RDNT

RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.

# Employees: 3729

Address: 1510 Cotner Avenue,Los Angeles,CA,USA

Phone: 310 478-7808

Fax: 310 478-5810

Website: www.radnet.com

Email:

Sector: Medical

Industry: MED-OUTP/HM CRE

Executive Officers

Howard G. Berger M.D. (Presi.; C.E.O.; Dir.)

Marvin S. Cadwell (Dir.)

David L. Swartz (Dir.)

Norman R. Hames (Dir.)

John V. Crues M.D. (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 3/15/2010

Mean EPS (Next Qtr): $0.01

Mean EPS (Year): $0.15

Mean Estimate(Long Term): $13.50

P/E Ratio(Based on EPS estimate): 13.870

Number of Estimates: 2

Shares Performance

Period	RDNT	Compare to S&P
YTD	-37.91 %	-48.61 %
4 Weeks	-29.97 %	-30.72 %
12 Weeks	-7.56 %	-12.85 %

Shares Information

Analyst Coverage: Y

Avg Volume: 233819

Shares Outstanding: 35M

Market Cap: $0.07B

52 Week High: $3.81

52 Week Low: $0.93

P/E Ratio: -0.010

PEG Ratio: 1.030

Split: On 1/1/1990 RDNT split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -120.00 %

EPS Growth in Last Year: -200.00 %

Sales Growth in Last Quarter: 1.72 %

Sales Growth in Last Quarter: 1.28 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: $1.57

Change in Payout Ratio: -0.010

Price/Sales: 0.140